Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis

NCT03920722 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Microscopic Polyangiitis (MPA)

Interventions

DRUG: Rituximab
DRUG: placebo

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]